Although our results have documented no relationships between AT-1R expression intensity and the listed clinicopathological parameters, in our opinion studies on the role of RAS in development of breast cancer should be continued, taking into account all proteins composing the system. This evidence concerns the gene AGTR1 and breast carcinoma.